Hundreds of psychedelics industry professionals and business owners gathered for a day of insights, education and networking at the third annual reMind Psychedelics Business Forum last week in Las Vegas.
The conference, hosted in conjunction with MJBizCon, brought together dozens of expert speakers and industry insiders who shared their experiences and offered advice for those looking to enter the field or to grow their existing business. Topics included cultivation, drug development, policy, regulations, investing and gray markets.
“We were thrilled to have such a great turnout for our third-annual event. The energy was incredible, the audience was highly engaged, and the networking room was buzzing all day,” said Sara Vaughn, VP Brand Leader of reMind. “It was also great being at the Las Vegas Convention Center, where we were able to be more strongly aligned with MJBizCon.”
Renowned psychedelic researcher Dr. Sue Sisley gave a stirring keynote address — “Unlocking the Power of Plant and Psychedelic Medicines” — in which she reflected on her decades-long fight to be able to study these medicines as a safe, effective treatment for end-of-life mental health care. She captivated the audience with a video about her mother’s use of psilocybin under the Right To Try law, which she strongly advocates expanding.
Joel Stanley, founder of Charlotte’s Web and Ajna BioSciences, opened the day with a talk titled “Nature’s Edge Over Synthetic Pharma,” in which he shared his inspiring journey pioneering FDA-approved botanical drugs for central nervous system therapies — and the profound impact they’ve had on many lives.
“Let’s be clear about what we’re doing here. This isn’t just business. This is a revolution in mental health care. We’re using medicine and building tools to tackle trauma, addiction, depression – the stuff that’s breaking people down every single day,” said Ricardo Baca, founder of Grasslands: A Journalism-Minded Agency, who also emceed the event. “The old ways aren’t working anymore. People are suffering. They’re looking for answers. And everyone in this room? We’re working on those answers.”
In addition to expert insights on decriminalization, gray markets, and “psychedelic-adjacent” products like kanna, kava, and mushroom growkits, the audience got practical advice from psychedelic healers and business owners operating in Oregon and Colorado, the nation’s first two state-regulated psychedelic marketplaces. The panel included Kat Thompson of Fractal Soul Service Center, Lisa Ginzburg of Changa Institute, and Matt Brockmeier of Antithesis Law PC, and was moderated by Henry Winslow of Tricycle Day.
After a networking lunch, attendees joined breakout sessions that enabled focused group discussions on specific topics led by experts in the field. David Rahn of R&A Psyins shared information and advice about insurance for psychedelic businesses. Jodi Green of Antithesis Law PC fielded questions about important legal issues that owners and operators face. David Traylor of Golden Eagle Partners discusses investment opportunities and market outlook. And Kat Thompson offered entrepreneurial insights and lessons she’s learned operating a psilocybin service center in Oregon.
The day of conference programming ended with a cocktail reception.
reMind also announced its fourth-annual Psychedelics Business Forum would be returning to a two-day format. The event will be Dec. 2-3, 2025, at the Las Vegas Convention Center.
